LifeMD, Inc. (LFMDP) stock
LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)
Close on Oct 30, 2026Market cap $110.38MP/E –Yield –
LifeMD profit margin
Profit margin (net margin) is net income as a percentage of revenue.
LifeMD's profit margin for the twelve months ending Jun 30, 2026 was 0.1%. For fiscal 2025 it was 7.4%, against -13.8% the year before. The highest annual figure on record is 7.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.4% | +21.2 |
| FY2024 | Dec 31, 2024 | -13.8% | −0.3 |
| FY2023 | Dec 31, 2023 | -13.5% | +24.8 |
| FY2022 | Dec 31, 2022 | -38.3% | +27.3 |
| FY2021 | Dec 31, 2021 | -65.6% | +91.7 |
| FY2020 | Dec 31, 2020 | -157.3% | −132.1 |
| FY2019 | Dec 31, 2019 | -25.2% | −10.3 |
| FY2018 | Dec 31, 2018 | -14.9% | +17.8 |
| FY2017 | Dec 31, 2017 | -32.8% | −11.6 |
| FY2016 | Dec 31, 2016 | -21.1% | −16.1 |
| FY2015 | Dec 31, 2015 | -5.1% | +59.4 |
| FY2014 | Dec 31, 2014 | -64.5% | −31.3 |
| FY2013 | Dec 31, 2013 | -33.2% | +33.0 |
| FY2012 | Dec 31, 2012 | -66.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -15.0% | −11.7 |
| Q1 FY2026 | Mar 31, 2026 | -17.7% | −17.3 |
| Q4 FY2025 | Dec 31, 2025 | 282.0% | +372.0 |
| Q3 FY2025 | Sep 30, 2025 | -6.3% | +2.4 |
| Q2 FY2025 | Jun 30, 2025 | -3.3% | +10.3 |
| Q1 FY2025 | Mar 31, 2025 | -0.4% | +15.0 |
| Q4 FY2024 | Dec 31, 2024 | -90.0% | −81.7 |
| Q3 FY2024 | Sep 30, 2024 | -8.7% | +7.1 |
| Q2 FY2024 | Jun 30, 2024 | -13.6% | +5.2 |
| Q1 FY2024 | Mar 31, 2024 | -15.3% | −3.2 |
| Q4 FY2023 | Dec 31, 2023 | -8.3% | +34.1 |
| Q3 FY2023 | Sep 30, 2023 | -15.9% | +7.3 |
| Q2 FY2023 | Jun 30, 2023 | -18.7% | +24.0 |
| Q1 FY2023 | Mar 31, 2023 | -12.1% | +33.7 |
| Q4 FY2022 | Dec 31, 2022 | -42.4% | +23.6 |
| Q3 FY2022 | Sep 30, 2022 | -23.2% | +34.4 |
| Q2 FY2022 | Jun 30, 2022 | -42.7% | +32.7 |
| Q1 FY2022 | Mar 31, 2022 | -45.8% | +18.0 |
| Q4 FY2021 | Dec 31, 2021 | -66.1% | +184.1 |
| Q3 FY2021 | Sep 30, 2021 | -57.5% | +129.8 |
| Q2 FY2021 | Jun 30, 2021 | -75.4% | −38.3 |
| Q1 FY2021 | Mar 31, 2021 | -63.8% | −8.1 |
| Q4 FY2020 | Dec 31, 2020 | -250.1% | −232.1 |
| Q3 FY2020 | Sep 30, 2020 | -187.4% | −157.2 |
| Q2 FY2020 | Jun 30, 2020 | -37.2% | −6.9 |
| Q1 FY2020 | Mar 31, 2020 | -55.6% | −31.0 |
| Q4 FY2019 | Dec 31, 2019 | -18.0% | +17.0 |
| Q3 FY2019 | Sep 30, 2019 | -30.2% | −10.3 |
| Q2 FY2019 | Jun 30, 2019 | -30.3% | +21.2 |
| Q1 FY2019 | Mar 31, 2019 | -24.6% | −63.6 |
| Q4 FY2018 | Dec 31, 2018 | -35.0% | +188.6 |
| Q3 FY2018 | Sep 30, 2018 | -19.9% | +13.2 |
| Q2 FY2018 | Jun 30, 2018 | -51.5% | −163.2 |
| Q1 FY2018 | Mar 31, 2018 | 39.0% | +661.3 |
| Q4 FY2017 | Dec 31, 2017 | -223.6% | −160.8 |
| Q3 FY2017 | Sep 30, 2017 | -33.1% | −16.7 |
| Q2 FY2017 | Jun 30, 2017 | 111.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -622.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -62.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -16.4% | – |